Left atrial appendage occlusion using the Watchman device has emerged as an alternative
treatment strategy for preventing strokes in patients with atrial fibrillation. However, there is …

Background Large, randomized trials have established the safety and efficacy of left atrial
appendage occlusion (LAAO) for stroke prevention in patients with nonvalvular atrial …

Background Left atrial appendage occlusion (LAAO) has emerged as an alternative strategy
to oral anticoagulation for mitigating ischemic stroke risk in selected patients with atrial …

Percutaneous left atrial appendage occlusion (LAAO) provides a nonpharmacological
alternative of preventing stroke in patients with non-valvular atrial fibrillation who are poor …

Background: Left atrial appendage occlusion using a Watchman device has shown promise
in reducing stroke risk in selected atrial fibrillation patients. Limited data exist on differences …

Objective To determine trends in real‐world utilization and in‐hospital adverse events from
Watchman implantation since its approval by the Food and Drug Administration in 2015 …

Background: The Food and Drug Administration approved left atrial appendage occlusion
with the Watchman device for patients who are at increased stroke risk and are suitable for …

Background Left atrial appendage occluder (LAAO) implantation is an alternative method for
stroke prevention in atrial fibrillation (AF) patients who are not eligible for long-term oral …

Objective Percutaneous left atrial appendage occlusion (LAAO) is an alternative strategy for
prevention of thromboembolic events in patients with atrial fibrillation and unsuitable for long …

Patients with atrial fibrillation are at risk of developing a stroke, and the left atrial appendage
(LAA) is the most common site for clot formation. Although anticoagulation is the mainstay …